Crossmark

KCNQ1 and lymphovascular invasion are key features in a prognostic classifier for stage II and III colon cancer

Published Online: 2022-04-08

Published Print: 2022-12

Authors

Uil, Sjoerd H.

Coupé, Veerle M. H.

Bril, Herman

Meijer, Gerrit A.

Fijneman, Remond J. A.

Stockmann, Hein B. A. C.
License Information

Text and Data Mining valid from 2022-04-08

Version of Record valid from 2022-04-08
More Information

Article History

Received: 21 June 2021

Accepted: 24 March 2022

First Online: 8 April 2022

Declarations

:

: Tissue and data for the original protein biomarker publications was obtained in compliance with the ‘Code for Proper Secondary Use of Human Tissue in The Netherlands’ and conform local and national legislation that was applicable at the time. In the present manuscript we made use of the previously published data to build a classifier. Considering the consent rules from the previous publications apply to the data that were obtained, the present work has not been reviewed by the IRB separately.

: Not applicable.

: Two authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Prof. Meijer reports non-financial support from Exact Sciences, Sysmex, Sentinel CH. SpA, Personal Genome Diagnostics (PGDX), Hartwig Medical Foundation. In addition, Prof. Meijer has several patents pending. Dr. Fijneman reports grants and non-financial support from Personal Genome Diagnostics, and grants from MERCK BV. In addition, Dr. Fijneman has several patents pending. The other authors declare that they have no competing interests.

Document is current